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FORWARD 
   
 This thesis presents data collected during my master’s program. The data collected and 
presented here describes the role of resident tissue macrophages in the peripheral nervous system with 
an emphasis on their contribution to chronic pain states. The phenotype of resident tissue macrophages 
was poorly established especially in context to more widely known blood monocytes and microglia. 
Further we demonstrate the transient changes in resident tissue macrophages in the dorsal root ganglia 
were established, highlighting the up regulation of extra cellular proteins such as MHC Class II and 
CD39. This work will be submitted to a peer review journal upon completion of a few follow up 
studies. 
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ABSTRACT 
 
POTENTIAL ROLE OF DRG MACROPHAGES IN CHRONIC PAIN 
by 
Scott Scarneo  
University of New England, May, 2017 
 
 Persistent pain remains a significant burden on the US healthcare system with more than 100 
million patients experiencing persistent pain annually. Complex etiology coupled with functional 
plasticity of cells involved often results in a chronic health concern with limited treatment modalities. 
To date, most work aimed at describing neuro-immune interactions in pain focuses on the site of injury, 
leaving the functional significance of resident tissue macrophages in the dorsal root ganglia largely 
unexplored in both uninjured and peripheral injury states. Here, we systematically evaluate the 
phenotype of naïve DRG resident tissue macrophages and compare to naïve spinal microglia and bone 
marrow derived monocytes. We report the upregulation of CD39 and MHC Class II by DRG 
macrophages 24 and 72 hours following distal insult in multiple models of inflammatory pain. Further, 
we demonstrate functional changes induced in DRG macrophages in response to peripheral injury by 
profiling the cytokine proteome: DRG expression of 111 cytokines were evaluated with and without 
injury. Taken together, these data suggest that resident tissue macrophages actively respond to distant 
injury stimuli with functional changes and may influence nociception via neuro-immune 
communication.  
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CHAPTER 1 
INTRODUCTION 
 Chronic pain remains a prevalent health concern. Despite affecting up to 100 million patients 
in the U.S. alone, the underlying disease mechanism still remains relatively unresolved [1]. One 
underlying mechanism contributing to chronic pain may be the synergistic communication between 
immune cells and neurons. Interactions amid pain and inflammation have established for centuries, 
however mechanisms of neuro-immune interaction in response to injury remain unclear [2]. Current 
therapeutics aimed at regulation of inflammation, such as non-steroidal anti-inflammatory drugs 
(NSAIDs), often fail to alleviate severe pain and are short acting [3]. Understanding how specific 
genetic, psychological, and physiological properties contribute to the development of chronic pain will 
aid in the development of novel non-opioid compounds [4]. 
 
Neuronal Pathology of Pain 
 Conscious perception of nociception is essential for life, allowing human beings to detect 
harmful stimuli [5]. Under normal circumstances, pain is indicative of a potentially harmful stimulus 
directly affecting tissue. Nociceptors, specialized receptors present on nerve endings, detect thermal, 
chemical, and mechanical stimuli within their cutaneous and visceral targets [6]. Specific nerve fibers 
within the peripheral nervous system (PNS) transmit pain: class A () myelinated fibers and 
unmyelinated class C fibers. Class A () fibers are responsible for carrying sharp and fast initial pain 
transmissions, whereas class C fibers aid in the transmission of duller and slower pain signals [7]. 
Transmission of these signals, nociception, is accomplished via synapse of primary afferent neurons 
with secondary afferent axons in the dorsal horn of the spinal cord. The signal then continues up the 
contralateral spinothalamic tract to synapse in the ventroposterolateral (VPL) nucleus and 
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ventroposteroinferior (VPI) nucleus of the thalamus with conscious perception of pain occurring with 
synapse in the primary somatosensory cortex [9,10]. 
In some cases, pain persists even after the removal of noxious stimuli and the return to normal 
cellular physiology [8]. The term neuropathic pain is defined as pain which derives from a direct 
consequence of damage or disease to the somatosensory system [9]. It remains to be determined 
whether neuropathic pain and chronic pain are one and the same or distinct subclasses of persistent 
painful conditions. However, the complexity of these conditions and urgency for development of novel 
non-opioid therapeutics is consistently agreed upon [8]. Although persistent pain has been documented 
clinically for many years, the exact cause and pathology continue to be elusive. This in part arises 
from the plasticity of the primary afferent neurons, in which cellular processes are modified in 
response to inflammation or direct nerve damage [10]. Hyperalgesia, an increased sensitivity to pain 
stimulus, is an often observed clinical aspect of persistent pain. Primary hyperalgesia occurs directly 
at the site of injury within tissue and may be specifically dependent on persistent inflammatory 
processes, whereas secondary hyperalgesia is mediated a distance from the injury with unknown 
immune contribution [11]. Changes in neuronal transmission of pain may develop into alloydnia, a 
condition in which a previous innoculous stimulis is perceived as noxious under persistent pain states 
[12].  
Receptors and ion channels expressed on neuronal cell surface play a large role in the 
transmission of noxious stimuli within the pain pathway and expression characteristics aid in 
distinguishing one neuron from another in their biology and transmissory ability [13]. For example, 
the transient receptor potential (TRP) family of ligand-gated ion channels are a class of receptors 
frequently expressed on nociceptor neurons that respond to temperature [14] . TRP channel expression 
isn’t the only distinguishing mark of nocicpetors however; there are other varying sodium channels 
and neuropetptides which help discern neuronal sub type and function [15]. 
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 G coupled protein receptors (GPCRs) are another group of receptors with high levels of 
neuronal expression, though many other tissues express GPCRs as well. The diverse family of GPCRs 
all share a characteristic 7 transmembrane passing protein domain and play an important role in 
transducing extracellular signals. Intracellular G protein signaling is induced by binding of a plethora 
of ligands including hormones, neurotransmitters and cytokines to their respective GPCR [16]. 
Following extracellular binding, intracellular G protein subunits , , and  are further activated 
through GTP/ GDP exchanges induced by conformational changes in the corresponding GPCR upon 
ligand binding. Ligand binding and subsequent G protein initiation lead to a wide variety of 
downstream intracellular changes dependent on the specific combinations of G protein subunits 
coupling with the GPCR [17].  
Major GPCR classifications  
 Gs coupled GPCRs serve to increase neuronal excitability by increasing adenylyl cyclase 
activity downstream of the s subunit [18]. Elevated cAMP levels within the cytoplasm cause 
activation of protein kinase A (PKA), an immediate effector kinase capable of modulating activation 
status of other downstream effectors. PKA also regulates transcriptional activity as well as modulates 
cell membrane compositions [19].  
Contrary to Gs -coupled receptors, Gi/o –coupled receptors inhibit effects of 
neurotransmitters within neurons. Gi/o subunit activity inhibits adenylyl cyclase, directly opposing 
Gs signaling activity [20]. In addition to these effects, Gi/o signal cascades inhibit neurotransmitter 
release in the synaptic cleft. Reduction in postsynaptic neurotransmitter availability subsequently 
decreases signaling between neurons; within sensory neurons the result may include increased pain 
thresholds by reducing flux through afferent signaling pathways.  
Finally, Gq/11 –coupled receptors biochemical pathway operates through phospholipase C 
Beta (PLC). Down stream effectors include phosphatidylinositol-4,5-bisphosphate PIP2 leading to 
 
13 
 
(IP3) initiated (Ca2+) release from intracellular calcium storages [21].Alternatively, Gq/11 activation 
activates diacylglycerol (DAG) which may also aid in the increase in intracellular calcium levels. 
Heightened levels of calcium within the cytoplasm cause activation of protein phosphatase calcineurin 
further facilitating stimulating the NFAT transcriptional factors [22].  
Purinergic receptors  
Purinergic receptors are a specialized family of GPCRs of particular importance. P2 receptors 
are expressed primarily on neurons that respond to extracellular signals such as ATP as well as other 
purine and pyrimidine nucleotides. Studies have shown both P2X and P2Y receptors participate in the 
processing of sensory information including pain [23]. 
Previous work demonstrates via RT-PCR analysis that the mRNAs of three P2Y receptors, 
P2Y12, P2Y13 and P2Y14, are upregulated 4 days following CFA injection in murine dorsal hind paw 
[24]. These findings suggest modulation of P2Y expression and potentially functional response to 
peripheral injury. Further work shows that P2Y12 receptor expression in lumbar ganglia is limited to 
unmyelinated neurons within the sensory ganglia whereas expression of P2Y13, and P2Y14 
expression are seen on both myelinated and unmyelinated neuronal cell bodies [24] . P2Y12, P2Y13, 
and P2Y14 receptors signal through the Gi/o signaling pathway. It stands to reason then that these 
receptors may play a role in modulating pain response in murine peripheral nerve injury models. 
Indeed, unpublished data collected in the Molliver laboratory have shown that treatment with P2Y 
agonists exert anti-nociceptive responses following forskolin. Thus, P2Y signaling may be of 
particular importance in restoring neuronal cell homeostasis following nerve injury. 
Neuronal support: satellite glial cells  
 Satellite glial cells (SGC’s) tightly adhere and wrap around neuronal cell bodies in ganglia, 
and can mediate cell signaling. These specialized Schwann cells are primarily found within sensory, 
sympathetic and parasympathetic ganglia [25]. Originally believed to have complex processes similar 
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to astrocytes in the brain, it is now known these cells are laminar in morphology with often more than 
one cell interacting with a sensory neuron [26]. Close proximity of neurons and satellite glial cells, 20 
nm apart, provide the potential for robust proximal signaling between the two [23]. Signaling is further 
enhanced by microvilli which extend from the neuronal cell surface into the extracellular space, and 
invaginations of the satellite glial cells in some cases increasing the neuronal cell surface by up to 30-
40% and the interactions between satellite glial cells and neurons [27].  
In addition to their close spatial relation to neuronal cell bodies, it has also been demonstrated 
that satellite glia share the ability to communicate through intercellular messengers including ATP 
[28]. The presence of purinergic receptors for ATP, as well as other neurotransmitter receptors, have 
been explored on satellite glia data suggest neuronal communication with satellite glia [29]. Further 
work has implicated nitric oxide as a critical mediator of signal transduction between neurons and 
satellite glial cells. In naïve states 5% of sensory neurons express neuronal nitric oxide synthase 
(nNOS), however under pathological conditions expression is markedly upregulated, leading to 
subsequent elevated NO levels in neurons [30]. Further, Aoki et al. demonstrated high levels of cyclic 
GMP (cGMP), which is upregulated in response to NO, in satellite glial cells[32]. Concurrent elevation 
of arginine levels found by the same group suggests existence of an inhibitory feedback loop [31]. 
These discoveries led to the proposal of a mechanism of signal transduction in which neurons, under 
pathological stress, upregulate nNOS activity and its product NO, which signals in paracrine fashion 
to upregulate cGMP signaling in satellite glial cells [31].  
 
Relevant immune cells and inflammatory contribution to pain signaling 
Macrophages  
 Macrophages are critical mediators of the innate immune response. While traditionally 
macrophages have been defined as originating from bone marrow derived monocytes, recent work by 
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Perdiguero et al. in 2014 demonstrates that populations of yolk sac derived tissue resident 
macrophages are distinct from macrophages arising from bone marrow derived monocytes [32]. Bone 
marrow derived monocytes are continuously regenerated in bone marrow throughout adulthood and 
circulate in the blood stream, activating into macrophages only upon stimulation by extracellular 
factors such as pathogen associated molecular patterns (PAMPs) or damage associated molecular 
patterns (DAMPs) [33, 34]. Conversely, tissue resident macrophages differentiate in the prenatal 
period and persist throughout adulthood in the tissue of origin [35]. It is still unclear whether blood 
monocytes are able to replenish tissue resident macrophage populations on an as needed basis [36]. 
Both bone marrow derived and tissue resident macrophages mediate inflammatory response, acting as 
the cellular bridge between innate and adaptive response by taking on the role of major cytokine and 
chemokine manufacturing sites and by exhibiting the ability to upregulate and express the antigen 
presentation complex MHC Class II [37].  
 An additional macrophage classification system is useful in delineating specific cell functions. 
M1 macrophages contribute to the pro-inflammatory response whereas M2 macrophages are trophic 
or anti-inflammatory [38]. The dichotomy is derived from the distinct metabolic processing of 
arginine. M1 macrophages convert arginine to NO, a reactive oxygen species (ROS), through 
inducible nitric oxide synthase iNOS whereas metabolic processing of arginine by arginase in M2 
macrophages inhibits iNOS activity by out competing substrate availability [39, 40]. This reduces the 
inflammatory response through reduction of ROS in the cell [38]. These phenotypic classifications are 
not mutually exclusive but rather they highlight the complexity of macrophages in that macrophages 
are not terminally differentiating cells, differentiated phenotypes are modifiable by alterations in 
microenvironment and significant crossover exists between the M1 and M2 phenotypes [41]. 
 Macrophages isolated from mammalian tissues are notoriously difficult to identify due to the 
overlap of expression of many significant cell surface proteins between various leukocytes. A number 
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of parameters are described in chapter II and chapter III to define macrophage or monocyte populations 
or to exclude extraneous populations. For reference, a description of these markers is provided here. 
CD11b- A common macrophage marker used to aid in delineating cell type is Cd11b. Cd11b, also 
known as integrin alpha M (ITGAM), has been implicated in cell adhesion, migration, phagocytosis 
and cell activation [42].The protein is a subunit of the greater heterodimeric (M -2) protein known 
as macrophage-1 antigen (Mac-1) with the common chain 2 or also known as cluster differentiation 
molecule CD18 [43]. CD11b is not exclusive to macrophages and monocytes with expression 
demonstrated on related leukocytes in the innate immune system including dendritic cells, 
granulocytes and natural killer cells [42].  
CD11c- an additional integrin, often used to identify dendritic cells. Similar to Cd11b, Cd11c is a 
subunit of the heterodimeric protein in conjunction with 2 [44]. Although expression can often 
overlap that of Cd11b, high expression has been found on dendritic cells in human and murine species, 
thus CD11cmedium –high expressing Cd11b cells are often described as classical dendritic cells (cDC’s). 
Expression has also been found on naïve alveolar macrophages at levels that mimic cDC’s [45]. 
CD103- Cluster of differentiation protein 103 is used in identification of a small subpopulation of 
intestinal classical dendritic cells with expression ranging from 20-30% of total leukocyte population 
in the intestinal track[45]. Hence, these cells are further characterized as CD103+ cDC’s. CD103+ 
cDC’s are also found in most connective tissues [46] .  
CD115- Macrophage colony stimulating factor receptor or colony stimulating factor 1 receptor 
(CSF1r; CD115) is a receptor found on the surface of macrophages and other innate immune cells 
which acts as the receptor to the cytokine colony stimulating factor- 1 ligand [47]. This cytokine plays 
a role in production, subsequent differentiation, migration, and function of macrophages.  
CD169- Siglec-H or CD169 is a surface adhesion molecule found on macrophages which binds the 
sialic acid residues on other cells [48]. Moreover, it has been seen that CD169 can adhere to red blood 
 
17 
 
cells and thus is highly expressed in organs which filter blood such as the spleen [49]. Under pro 
inflammatory states CD169 is upregulated on macrophages  [50]. 
Ly6G- a neutrophil specific cell surface protein; allows distinction from other myeloid derived 
leukocytes [51]. Ly6G is an extracellular protein expressed in a highly regulated fashion from 
progenitor bone marrow cells throughout development and differentiation of neutrophils [52]. High 
Ly6G expression in Cd11b+ cells is used to define neutrophil lineage cells.  
Major histocompatibility complex class II (MHC Class II) expression occurs on immune cells capable 
of presenting antigen to CD4 helper T cells, including macrophages, dendritic cells, and some B 
lymphocytes [53]. This expression profile contrasts major histocompatibility complex class I (MHC 
Class I) protein complexes, which are present on all mammalian cells with a nucleus and are viewed 
as ‘self’ identifiers by effector immune cells including NK cells and CD8 cytotoxic T lymphocytes 
[54]. MHC Class I recognition prevents inappropriate NK cell killing response and facilitates proper 
activated CD8 T lymphocyte response by presenting self antigen on healthy self cells while stress 
antigens or foreign antigens are complexed with MHC Class I on unhealthy self cells, thus allowing 
immune response against invaded cells [55, 56]. Under healthy physiological conditions macrophages 
exhibit MHC class I complexes much like other self cells, however upon stimulation by PAMPs or 
DAMPs macrophages upregulate expression of MHC Class II membrane proteins [57]. In response to 
foreign antigens macrophages phagocytize invaders and present protein fragments (antigens) via MHC 
Class II complex [58]. Hence, MHC Class II expression is often correlated with antigen detection and 
subsequent antigenic presentation to other immune cells, leading initiation of the adaptive immune 
response.  
CX3CR1- CX3C chemokine receptor 1, or fractalkine receptor, is a membrane bound protein involved 
in adhesion and migration of mononuclear leukocytes [59]. Expression of this protein has been found 
on macrophages, monocytes and microglia where its expression is often linked to cell survival [62]. 
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Additionally, in the central nervous system CX3CR1 expression on microglia has been found to play 
a role in activation and migration of microglia to damaged regions of CNS where they may undergo 
phagocytosis [60]. 
CD39- The ectonucleoside triphosphate diphosphohydrolase 1, E-NTPDase1 or cluster of 
differentiation 39 (CD39), is an extracellular protein with an active domain open to the extracellular 
milieu [61]. CD39 responds to extracellular purinergic signaling molecules, primarily ATP. CD39 
mediates ATP availability by catalyzing the hydrolysis of ATP to AMP, which can be further 
converted via CD73 into adenosine [62]. In some persistent pain states elevated levels of ATP have 
been found in the DRG following peripheral injury [102]. Thus, macrophages may have the ability to 
mediate purinergic signaling by modulation of available ATP/AMP substrate. Interestingly, adenosine 
has been reported to dampen inflammatory response and allow pro inflammatory cells to return to a 
more quiescent state [63]. Together, this data leads to the hypothesis that insufficient DRG 
macrophage CD39 activity may contribute to persistent pain states by limiting flux through the 
metabolic pathway of ATP to adenosine conversion. 
CCR2- Expression of chemokine receptor-2 (CCR2) has been documented on macrophages, 
monocytes as well as other migrating leukocytes [64]. This extracellular receptor for the ligand (CCL-
2) plays an important role in cell migration. Recent data suggest up regulation of the CCR2 ligand, 
CCL2 in mRNA levels in DRG of peripherally injured rats [65]. 
 
 
 
 Cd11b CD11c CD39 CD103 CD169 MHC II CX3CR1 CCR2 Ly6G Ly6C 
Macrophages  ++ + +++ - + +++ +++ + - + 
Monocytes  ++ NK + - + + + ++ - ++ 
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Neutrophils  + - - - - - NK NK +++ - 
CD103+ cDC’s +/- +++ NK + NK ++ NK NK - NK 
cDC’s + +++ NK - NK ++ NK NK - NK 
Microglia  + NK + - NK - + - - - 
Table 1.1 – Expression of phenotypic lineage markers by leukocyte populations in mice.  
*NK= Not currently known, or agreed upon  
 
Macrophage expression of purinergic receptors 
Macrophages have also been shown to express P2X and P2Y receptors. P2Y12, P2Y13, and to 
a greater extent P2Y14 have been demonstrated. P2Y14 receptors act to inhibit adenylyl cyclase 
activity, further inhibiting the production of cAMP [66] . The endogenous ligand for P2Y14 is UDP-
glucose- an important nucleotide sugar involved in glycotransferase reactions in glycogen metabolism. 
Often found in the cytoplasm, UDP-glucose may also be transferred to the cell membrane and released 
[67].  
Cytokines involved in macrophage function 
 Cytokines, the most prevalent immune signaling molecules, act as intercellular messengers. 
These small proteins usually less than 30 kDa in size mediate the carefully choreographed immune 
response to foreign antigens and are loosely categorized as pro or anti inflammatory, however 
significant overlap occurs depending on the full cytokine milieu [68, 69]. For context, cytokines 
involved in macrophage differentiation and function are briefly described. 
Pro-inflammatory cytokines polarize bone marrow derived monocytes or tissue resident macrophages 
into pro-inflammatory effector cells, upregulating migration, phagocytosis and antigen presentation 
[70]. Pro-inflammatory cytokines include IL-1a, IL-1ra, IFN-, CXCL2, CCL2. CD14, Tumor 
necrosis factor  (TNF-), and granulocyte macrophage colony stimulating factor (GM-CSF). While 
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these are primary members of the classical inflammatory milieu, many other inflammatory cytokines 
have been documented [71, 72].  
Trophic cytokines promote function of the trophic macrophage response important for wound healing. 
A hallmark of trophic macrophage activity is reduced production of the reactive oxygen species nitric 
oxide, which is a key component of inflammatory macrophage response. The reduction in NO 
production can be attributed to substrate competition for the arginine precursor achieved by 
upregulation of the enzyme arginase in M2 macrophages. The net effect of arginase upregulation is 
significant reduction in arginine availability for activity of the inducible nitric oxide synthase enzyme 
(iNOS). Cytokines supporting an trophic-inflammatory or trophic macrophage response include IL-4, 
IL-10, Il-13,serepin E1, MMP3 and TGF- [73]. These important mediators of the immune system 
initiate the return to homeostasis once the pro-inflammatory stimulus has been resolved and allow for 
tissue repair to begin [74] . 
Central Nervous System- immune interactions  
 The discovery of microglial cells by Franz Nissi shed light on the presence of immune entities 
in the central nervous system [75]. Similar to macrophages in the periphery, microglia act as first 
responders to injury in the central nervous system by quickly mobilizing and differentiating into 
functional states reactive to CNS insult [76]. Microglia are capable of polarization rapidly and with 
high efficiency into pro or trophic-inflammatory phenotypes dependent on extracellular stimuli. Due 
to their dichotomous nature, tight regulation of microglial activation is needed to prevent unwanted 
damage in central nervous tissue. Microglial activation is primarily mediated through receptors where 
either of two categories may be received: “off” and “on” signals [77]. The “off” signal inhibits 
potentially damaging inflammatory activation. “Off” receptors include CD200R, as well as P1A3 
which tonically retain the muted state of microglial cells [78]. “On” receptors include purinergic 
receptors such as P1 adenosine receptors, P2 ATP receptors, as well as receptors for advanced 
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glycation end products (RAGE) and others [79].In microglia, the existence and expression of P2X4, 
P2X7, P2Y2, P2Y6 and P2Y12 have been previously investigated [80]. Studies have shown that 
intrathecal injection of ATP stimulates microglia and initiates mechanical hypersensitivity as well as 
release of brain derived neurotrophic factor (BDNF) [81]. Overall, regulation of microglial activation 
plays a critical role in CNS injury response. 
Peripheral nervous system- immune interactions. 
Previous research has demonstrated some neuro-immune interactions in the periphery. In 1993, 
Maves and colleagues were able to evoke neuropathic pain in the absence of direct peripheral nerve 
injury by transplanting chromic gut sutures proximal to the sciatic nerve, leading to immune response 
and subsequent neuropathy [82]. These data provided the initial suggestion that neuropathic pain may 
be mediated at least in part by the immune system and that cross cell communication may be taking 
place. Further studies have shown neuronal communication with immune cells through 
neurotransmitters [83]. Research conducted by Pacheo, et. al. highlight the role of neurotransmitter 
receptors, specifically dopamine receptors (DAR’s), in immune response [84]. To date five DAR have 
been identified and are neuronal GPCR’s primarily activated through endogenous dopamine and 
analogs [89]. Interestingly, all five dopamine receptors have been reported to also be expressed on T 
cells. Findings indicate that of the five, only one, D3R, promotes inflammatory T cell stimulation. 
Investigation of the other four DAR’s have shown they play a critical role in the induction of inhibitory 
signals. D3R signaling activation promotes production and secretion of IFN while also inhibiting IL-
10 and IL-4 synthesis in T cells [84]. Evidence of leukocyte response to neurotransmitters may help 
elucidate the means by which the immune system reacts to nerve tissue damage and signaling. 
Likewise, research has shown that microglia cells are able to produce and secrete neurotransmitters 
[84]. 
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 The complex interactions between immune cells and neurons remain widely unknown, 
however recent data suggests that macrophages may be involved in the development of persistent pain 
[85]. We have confirmed the existence of resident macrophages in the dorsal root ganglia (DRG) of 
naïve mice of multiple strains; these results are detailed in chapter II. We further explore the function 
of tissue resident macrophages in sensory ganglia in subsequent chapters.  
 Overall, the role of macrophages in the peripheral nervous system has yet to be elucidated in 
response to injury. In order to better understand the significance of resident macrophages in pain 
response to peripheral nerve stimuli, we characterized the resident immune system in the DRG with 
use of a transgenic mouse model. Initial findings of resident tissue macrophages were confirmed 
through fluorescent imaging of eGFP expressing macrophages in the DRG of uninjured mice. Further, 
we hypothesize that not only do resident tissue macrophages exist in the naïve ganglia but they respond 
to neurons in persistent pain states though phenotype changes. 
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CHAPTER 2 
IMPACT OF RESIDENT TISSUE MACROPHAGES IN PERSISTENT PAIN 
 
ABSTRACT 
 Pain is relevant to all clinical settings and a unifying force across specialties, though it remains 
a burden on the US Health Care System. The development of persistent pain is preceded by 
sensitization of central nociceptive pathways by mechanisms incompletely understood. Resident tissue 
macrophages have been previously described in many tissue types, however peripheral nervous system 
macrophages are less well described. Here we characterized the morphology and naïve phenotype of 
resident tissue macrophages using flow cytometry and immunohistochemistry.  Phenotypically 
distinct, compared to microglia and blood monocytes, >90% resident tissue macrophages in the dorsal 
root ganglia express MHC Class II,  CX3CR1, and CD39, with few <1% of cells positive for other 
leukocyte phenotype markers including CD103, Cd11c, and Ly6G. Approximately 50% of resident 
tissue macrophages express the monocyte chemokine attractant receptor CCR2. Inflammatory pain 
model complete Freund’s adjuvant, show resident tissue macrophage response to peripheral injury by 
exhibiting increased expression of CD39 and MHC Class II and an altered cytokine proteome profile, 
suggesting altered macrophage function on detection of distant insult. This taken together indicates a 
distinct phenotypic immune cell population in naïve dorsal root ganglia with a potentially distinct 
functional value under persistent pain states. 
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METHODS 
Animals – All mice were housed and cared for in accordance of the University of New England 
Institution Animal Care and Use Committee (IACUC). Mice were housed in a temperature and 
humidity controlled facility under 12-hour light/dark cycle (lights on at 7 am) and access to food and 
water ad libitum. All experiments were undertaken under approved protocol in accordance with the 
institutional guidelines and the Guide for the Care and Use of Laboratory Animals. Csfr1-eGFP mice 
were purchased from Jackson Laboratory and used for IHC and peripheral inflammatory injury (CFA) 
as well as primary cell culture. Genotyping was performed by PCR using tail digests. Primers and 
PCR conditions for Csfr1-eGFP were carried out under the following conditions 95C for 5:00 
minutes, 30 cycles of 95C for 0:45s, 60C for 0:45s, 72C for 0:45s, followed by 72C for 5:00 
minutes. PCR results were imaged on 1.5% agarose gel.  
Transgenic Mice- B6N.Cg-Tg (Csf1r-EGFP) 1Hume/J mice were purchased from Jackson Laboratory 
and used for IHC and peripheral inflammatory injury (CFA) as well as primary cell culture. 
Genotyping was performed by PCR using tail digests. Primers and PCR conditions for Csfr1-eGFP 
were carried out under the following conditions 95C for 5:00 minutes, 30 cycles of 95C for 0:45s, 
60C for 0:45s, 72C for 0:45s, followed by 72C for 5:00 minutes. PCR results were imaged on 1.5% 
agarose gel. Primers listed in Appendix of Thesis.  
Immunohistochemistry- Mice were perfused transcardically with Hanks Balanced Salt Solution 
(HBSS) followed by 40 mLs of 4% paraformaldehyde (PFA). L3-5 DRG, spinal cord lumbar 
enlargement, and glabrous and hairy hind paw skin were dissected out and cryo-protected overnight 
in 30% sucrose, and embedded in Tissue-Tek Optimum Cutting Temperature (OCT) compound 
(Thermo Fisher Scientific, Waltham, MA). Serial sections of DRG (12 m), were mounted on 
Superfrost(+) slides (VWR, Radnor, PA). Cells were stained with antibodies against neuronal specific 
enolase (NSE) – (Genetex Cat#GTX85462), GFAP- (Biolegend Cat#914501). Slides were incubated 
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overnight at room temperature, washed 3 times for 15 minutes then stained with the following 
secondary’s, Donkey anti Rabbit IgG – PE ( Biolegend Cat#406421), Donkey anti Rabbit IgG –Ax 
647 (Biolegend Cat#406414), and Goat anti mouse IgG – Ax488 (Biolegend Cat#405315). 
Dorsal Root Ganglia Dissociation- Prepared Collagenase IV (Sigma-Aldrich, C5138) enzyme 
solution by added 3 mg of collagenase to 3 mL of HBSS (Ca2+/Mg2+ free). Enzymes were placed in 
37C water bath. L2-L5 bilateral DRG were removed in less than 20 minutes. Aspirate all solution 
from DRG solution and added 3mL of Collagenase IV solution via 0.2-micron filter. Incubated in a 
37C incubator for 20 minutes. Centrifuge at 150g for 2 minutes, remove all media, cells were 
reconstituted in 1 mL of HBSS (Ca2+/Mg2+ free) pH 7.2. DRG’s were triturated and pipetted through 
70 m filter. 
Flow Cytometry- Macrophages were isolated from naïve animals L2-L5 bilateral dorsal root ganglia. 
Rapidly dissociated as previously described. Cells were suspended in a 1% BSA in PBS solution with 
Fc Blocked (Biolegend Cat# 101310) for 30 minutes at 4C. Cells were spun down at 300g for 4 
minutes and Fc block solution removed. Cells were re-suspended in 100ul of 1% BSA in PBS solution 
and stained with pre conjugated antibodies against the following extra cellular proteins, CD11b-V450 
(BD Bioscience Cat# 560455), CD39- PE (Biolegend Cat# 143804), MHC Class II- APC-Cy7 
(Biolegend Cat#107628), LY6G-PE Tex Red (Biolegend Cat#127648), LY6C-BV570 (Biolegend, 
Cat#128029), CCR2-APC (Biolegend Cat# 150604), CD11c-Percp (Biolegend, Cat# 117326), 
CD103-Ax647 (Biolegend Cat# 121410), CD169-Ax488 (Cat# 42419), F4/80 –Percp (Cat# 123125) 
and CX3CR1-PE Cy 7 (Biolegend, Cat#149016). Cells were gated for lives cells using FSC-A and 
SSC-A parameters and further gated for singlet’s through SSC-A to SSC-H 1:1 ratio. Leukocyte 
populations were identified through back gating CD11b(+) population. 
Sciatic Nerve Crush- Sciatic nerve crush (SNC) was done as described. Briefly, mice were 
anesthetized by inhalation of isoflurane (4% for induction and 3% for maintenance) in 100% O2. The 
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left flank was shaved with surgical clippers and cleaned once with betadine solution. A small incision 
was made in the mid-thigh region of the left leg. The inner muscle was separated using forceps to 
expose the sciatic nerve. Using fine hemostatic forceps, the sciatic nerve was lifted out of the muscle 
with care taken not to stretch the nerve. The nerve was crushed using one click of the hemostatic 
forceps for 30 seconds. The wound was irrigated with sterile saline, and closed using a  5-0 polyglactin 
910 suture (Ethicon). Sham surgery was identical to the sciatic nerve crush surgery except that the 
sciatic nerve was exposed but not manipulated in any way. After the surgery, all mice were 
individually housed with food and water readily available.  
Injection of Complete Freunds Adjuvant (CFA) - Mice were anesthetized by inhaled isoflurane. 
Sterile syringe consisting of a 1:1 mixture of saline to CFA was used to inject 20 μl of CFA into the 
globourous hind paw skin. Mice survived for up to 1 or 3 days’ post injection. 
Bone Marrow Derived Macrophages – Acutely cultured bone marrow derived macrophages were 
obtained from tibia and femura of naïve male C57Bl/6J mice. Immature bone marrow cells were 
culture for 72 hours in L929 culture media to induce macrophage differentiation. Following 72 hour 
rest period in L929 media cells were treated with Capsaicin and CFA. 
Cytokine Assays- 3 Days following injection with either CFA or saline bilaterally into the hind paws, 
C57Bl/6J male and female mice (n=4 per condition) bilateral L2-L5 DRG were rapidly dissected and 
dissociated as previously described. Cells were plated for 16 hours in DMEM- High Glucose media 
supplemented with 10% FBS, 30% L929 conditioned media, and gentamycin. Following incubation 
for 16 hours’ supernatant was removed and spun down to remove any debris in media. Protease 
inhibitors were added to the supernatant. Protein quantification was performed on all samples to 
determine protein concentration. Cytokine assay was done as described by manufacturing protocol 
(R&D, XL mouse Cytokine Array A).  
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RESULTS. 
2.1 Macrophages exist in DRG of naïve male and female C57Bl/6J and BALB/cJ mice 
The expression of CD11b and Ly6G proteins within naive L2-L5 dorsal root ganglia of female and 
male C57Bl/6J and BALBc/j mice was analyzed by flow cytometry. CD11b expressing cells were 
found in both male and female C57Bl/6J naïve L2-L5 DRG (Figure 2.1 B). This finding was confirmed 
in another mouse strain: male and female BALB/cJ mice also express CD11b+ cell population in L2-
L5 naïve DRG (Supplemental Figure). In order to exclude the possibility that the CD11b+ population 
of cells found in mouse DRG may be a previously unidentified population of neutrophils, dissociated 
DRG were prepared and stained simultaneously with CD11b and Ly6G, a definitive neutrophil marker. 
Ly6G was found in an insignificant population of CD11b+ cells (< 1%) in L2-L5 DRG of either 
C57Bl/6J male or female mice (Figure 2.5). Similarly, dendritic cells were ruled out by evaluating 
expression of CD11c and CD103 within the sensory ganglia. Very small or no populations of CD11c 
cells with co-expression of CD11b (<1%) were found in the sensory ganglia (Figure 2.1 C.). 
2.2 CSF1R-eGFP reporter mice enable analysis of DRG macrophage morphology and localization 
Csf1r-eGFP resident tissue macrophages in naïve DRG were obtained from collagenase digested L2-
L5 DRG and stained for CD11b. Co-expression of CD11b and CD115-eGFP was found in DRG 
resident tissue macrophages and spinal cord with the majority (>95%) of CD11b cells co expressing 
CD115 (Figure 2.2 B, C).  
2.3-2.5 DRG macrophages localize surrounding neuronal cell bodies, independent of vasculature and 
satellite glia  
Immunohistochemistry was used to determine localization of macrophages within the naïve ganglia. 
The limited ability to perform IHC staining with currently available anti-CD11b antibodies, which 
target highly ex-vivo labile cell surface integrin’s normally only visible on in tact cells by flow 
cytometry, distribution of resident tissue macrophages was ascertained by immunostaining L4 naïve 
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DRG of CD115-eGFP mice. CD115 is the CSF1-R receptor expressed and required for survival of 
macrophages. Naïve L4 DRG were isolated from male B6N.Cg-Tg (Csf1r-EGFP) 1Hume/J mice. 
After flow cytometry analysis revealed co-expression of CD115 and CD11b without concurrent 
expression of Ly6G or CD11c in DRG macrophages, L4 DRG isolated from CD115-eGFP mice were 
prepared and stained with IHC antibodies against PGP9.5 to identify morphology and position 
proximal to neuronal cell bodies. A robust population of resident tissue macrophages in the dorsal root 
ganglia was observed with ramified processes, with close proximity to neuronal cell bodies (Figure 
2.3).   
Significant satellite glial cell populations also exist within the dorsal root ganglia surrounding 
neuronal cell bodies, thus, to exclude the possibility of glial expression of CD115 in the B6N.Cg-
Tg(Csf1r-EGFP)1Hume/J mouse line, naïve L4 DRG were stained for glial fibrillary acidic protein 
(GFAP). Satellite glia were found to be exclusive of CD115+ cells (Figure 2.4 D).  
Due to the highly vascular nature of the dorsal root ganglia, leukocytes may exist within the 
vasculature and not as part of the DRG microenvironment; thus it is possible that residual blood 
leukocytes may have been inadvertently captured at the time of analysis. To exclude this possibility, 
CD31, which is platelet endothelial cell adhesion molecule and is expressed on endothelial cells, was 
used to label blood vessels in naïve L4 DRG isolated from CD115 B6N.Cg-Tg (Csf1r-EGFP) 1Hume/J 
reporter line. CD115 expressing cells were found to be predominately exclusive of vasculature in the 
sensory ganglia (Figure 2.5 D).  
2.6 Phenotypic analysis of DRG macrophages reveals a distinct population of tissue resident cells 
 The phenotype of CD11b+/Ly6G-/CD11c- macrophages isolated from naïve mouse DRG 
resident tissue macrophage populations was analyzed by flow cytometry by staining with antibodies 
directed against CX3CR1, MHC Class II, CD39, LY6C, CD169, and CCR2. DRG macrophages were 
analyzed alongside blood monocytes and spinal microglia isolated from the same animal for 
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comparison. A single cell suspension of whole dissociated DRG, red blood cell lysed blood leukocytes, 
and dissociated lumbar spinal cord were prepared and stained prior to running the suspensions through 
a BD LSRII flow cytometer. Analysis consisted of first sorting by size and granularity to identify a 
live cell population consistent with macrophages, which are significantly smaller than neuronal cell 
bodies and satellite glial cells but larger and more granular than lymphocytes. Samples were then gated 
on CD11b+/Ly6G-/CD11c- cells where ‘gating’ refers to exclusion of all cells not found to express 
CD11b or that do express Ly6G or Cd11c (hereafter referred to as DRG macrophages). CX3CR1 (CX3 
chemokine receptor 1) was found to be highly expressed in majority (> 96%) of microglia and ~90% 
DRG macrophages isolated from naïve animals (Figure 2.6 A, C). This high expression of CX3CR1 
by DRG macrophages is a stark contrast to blood monocytes isolated from the same animals, in which 
45-50% of blood monocytes express medium to low levels of CX3CR1 (Figure 2.6 B). The antigen 
presentation molecule MHC Class II was found to be highly expressed on DRG resident tissue 
macrophages (~90%) compared to microglia (~10%) and blood monocytes (~4%) (Figure 2.6 D, F). 
 Flow cytometric analysis of CD39 on resident tissue macrophages, microglia and blood 
monocytes revealed that similar to microglia the majority of resident tissue macrophages in the DRG 
have high expression of CD39, compared to blood monocytes which are CD39 low to null expressing 
(Figure 2.6 G, H, I).  
Low expression of LY6C in DRG resident tissue macrophages and microglia was found 
compared to blood monocytes which have a higher overall expression of LY6C (Figure 2.6 J, K, L). 
50% of resident tissue macrophages in the sensory ganglia expressed CCR2 compared to low to null 
expression on microglia and approximately 25-30% of blood monocytes (Figure 2.6 M, N, O). 
2.7 Sprague Dawley Rats express significant resident tissue macrophage population in naïve L2-L5 
DRG.  
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 Macrophages isolated from female Sprague Daley rats were analyzed via flow cytometry. 
Significant population of CD11b+, LY6G- populations were discovered (Figure 2.7 B, E). Thus 
resident tissue macrophages are conserved across multiple species. Furthermore, these cells are 
predominately MHC II positive similar to C57Bl/6J male and female mice (Figure 2.7 E).  
2.8 Transient phenotypic changes induced by hind paw injection of CFA. 
Marked upregulation of CD39 and MHC Class II was recorded in DRG resident tissue macrophages 
24 hours following CFA injection (Figure 2.8 A, B, C) (n=4, *p< 0.05). Comparatively, no significant 
changes in expression of CD39 or MHC Class II were observed in microglia isolated from the lumbar 
enlargement of matched spinal cord (Figure 2.8 H, I, G). A significant increase in mid-level CD39 
expressing blood monocytes was observed (Figure 2.8 D, F), although no concurrent increase in MHC 
Class II was detected (Figure 2.8 E, F). 
2.9 Evaluation of acutely cultured bone marrow derived macrophages treated with CFA and capsaicin 
revealed no inducible change of CD39 of MHC II expression in treated cells. Differentiation of acutely 
cultured bone marrow cells was established through cytokine induced induction of M1 and M2 
macrophages. M1 differentiated cells markedly upregulated MHC Class II and iNOS where as M2 
upregulated arginase (Figure 2.9 A-C). Following successful pro and trophic-inflammatory 
polarization, differentiated cells were treated with high concentrations of CFA and Capsaicin at 100nm 
or 100ng/mL of capsaicin or CFA, respectively. No notable changes in CD39 or MHC II expression 
was seen in treated samples over control undifferentiated samples (n=3) (Figure 2.9 D-F).  
2.10-2.11 Cytokine and Chemokine profile in L2-L5 C57Bl/6J DRG 3 days following CFA injection   
Marked changes in the chemokine and cytokine profile of lumbar 2-5 DRG were observed 3 days 
following intraplantar CFA injection in male and female C57Bl/6J mice. Sex dependence of cytokine 
expression was variable: serepin-E1 was upregulated in both male and female mice following CFA 
injection (Figure 2.10, 2.11). Furthermore, female specific upregulation of MMP3, a trophic cytokine, 
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about 2 fold and pro inflammatory cytokines/chemokines CXCL2, CCL2, and CD14 in CFA treated 
animals. Down regulation of IFN- in female CFA treated animals 72 hours post CFA injection 
indicate a dynamic cytokine milieu following injury.  
 Similarly, males also exhibited biphasic cytokine response with both pro and trophic mediators 
expressed 3 days following peripheral injury with CFA. Stark down regulation of MMP3 in CFA 
treated animals was contrasted with upregulation of IL-13 and IL-4 in CFA treated mice. Pro 
inflammatory cytokines, IL-1a, IL-1ra and CD14 were significantly upregulated in CFA treated mice 
over saline treated. CCL2, an important chemokine in chemotaxis of leukocytes to injury was down 
regulated in male CFA animals.  
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Figure 2.1 
Significant CD11b + cell populations are found within naïve L2-L5 DRG. Resident tissue macrophages 
in naïve DRG were obtained from collagenase digested L2-L5 DRG and stained for CD11b. Both 
C57Bl/6J male and female mice contain significant CD11b+ cell populations in naïve animals( 
A,D,G,). Minimal neutrophil populations were identified as seen by minimal to no Ly6G expression 
of CD11b+ cells (B,H), and dendritic cells CD11c (C,I) in DRG macrophages and microglia.  
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Figure 2.2. CSF1R-eGFP reporter mice enable analysis of DRG macrophage morphology and 
localization. Resident tissue macrophages in naïve DRG were obtained from collagenase digested L2-
L5 DRG in CD115-eGFP transgenic reporter mouse and stained for CD11b (B). Additionally, blood 
monocytes (A), and spinal cord microglia (C) were isolated and stained against CD11b.       Co-
expression of Cd11b and eGFP was seen in a majority of CD11b+ cells.  
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Figure 2.3  
L4 DRG section from a naive male mouse expressing eGFP (green) driven by the CSF1R promoter. 
Double-labeling with antibodies to the neuronal marker PGP9.5 (red) indicates the presence of many 
eGFP-positive cells closely apposed to neuronal cell bodies.  
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Figure 2.4 
Spatial arrangement of CD115-eGFP cells (green) around neuronal cell bodies (red) and GFAP+ cells 
(blue) indicate absence of co localization between satellite glial cells (GFAP+) and immune cells 
(CD115 +). A. neurons (red, Ax 647), B. satellite glial cells (blue, Cy3), C. CD115+ cells (green, 
eGFP) and merged (D) within L4 naïve DRG.  
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Figure 2.5  
Immunostaining in L4 DRG with monoclonal antibodies against A. CD31 vasculature (PECAM) B. 
Neuronal specific enolase (NSE), C. CD115-EGFP (+). Localization of all three markers (D) indicate 
immune cells are exclusive of vasculature. 
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B.) Neuronal Cell Bodies  
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Figure 2.6 
L2-L5 DRG, blood, and lumbar enlargement of spinal cord were isolated from a naïve female 
C57Bl/6J mouse and stained with indicated markers. Graphs represent Ly6G-CD11b+ macrophages 
stained for CX3CR1 (a-c), MHC Class II (d-f), CD39 (g-i), Ly6C (j-l), and CCR2 (m-o).  
 
a)                               b)                               c)
 d)                               e)                               f)
  g)                              h)                               i)
  j)                                k)                              l)
 m)                              n)                              o)
F
S
C
-A
F
S
C
-A
F
S
C
-A
F
S
C
-A
F
S
C
-A
F
S
C
-A
F
S
C
-A
F
S
C
-A
F
S
C
-A
F
S
C
-A
F
S
C
-A
F
S
C
-A
F
S
C
-A
F
S
C
-A
F
S
C
-A
        CX3CR1
     MHC Class II
          CD39
           Ly6C
          CCR2
                                                     
DRG                    Blood                Spinal Cord 
        CX3CR1
     MHC Class II
           CD39
           Ly6C
          CCR2
        CX3CR1
     MHC Class II
          CD39
           Ly6C
          CCR2
 
38 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7 
Blood, DRG and Spinal Cord were collected from naïve Sprague Dawley male rats by cardiac puncture 
and dissection, respectively. All tissues were stained with antibodies against CD11b, Ly6G, and MHC 
II. Graphs (A, B, C) were gated on live, singlet cells determined by forward and side scatter analysis. 
Graphs (D, E, and F) were gated on CD11b+, Ly6G- cells.  
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Figure 2.8 
Up regulation of CD39 and MHC II on CD11b + Ly6G – mononuclear cells following CFA injection 
in L2-L5 murine DRG in male C57Bl/6J mice. Specific upregulation of MHC II on DRG resident 
tissue macrophages (c). No significant upregulation of MHC II on blood monocytes or microglia (f, 
i). Fold change calculated by percent of cells in gate, *, p <0.05.   
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Figure 2.9 
Bone marrow was isolated from femora and tibiae of female wildtype C57Bl/6J mice and cultured. A-
C: Undifferentiated (grey), M1 (blue) or M2 (green) macrophages were induced. Control 
differentiation (a, b, c) expression changes in M1 marker iNOS and M2 marker arginase are shown 
for reference. D-F:  Capsaicin 100nm (blue) or CFA 10ng/mL (green) was added to undifferentiated 
culture and levels of iNOS, arginase and CD39 were measured after 24 hours.  
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Figure 2.10  
3 Days post either bilateral CFA injection or saline in the hind paws, C57Bl/6J female L2-L5 DRG 
were rapidly dissected and dissociated into culture media. Cells were cultured for 16 hours. 
Chemokine and cytokine production were evaluated from both saline(Grey) and CFA treated 
mice(Blue). n=4,     * p< 0.05, two tailed student’s t –test.  
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Figure 2.11  
3 Days post either bilateral CFA injection or saline in the hind paws, C57Bl/6J male L2-L5 DRG were 
rapidly dissected and dissociated into culture media. Cells were cultured for 16 hours. Chemokine and 
cytokine production were evaluated from both saline(Grey) and CFA treated mice (Blue). n=4,     * 
p< 0.05, two tailed student’s t –test.  
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CHAPTER 3 
DISCUSSION 
 Studies show that nearly 100 million people suffer from chronic pain in the U.S. today [1]. 
Current therapies to treat pain, including opioids and NSAIDS, come with undesired side effects and 
often fail to provide lasting benefits. Understanding the basic mechanisms of pain in the ascending 
pathway and novel interactions between neurons and surrounding cells in the sensory ganglia is the 
first step to designing and implementing novel therapies.  
 Here we have shown that not only do significant macrophage populations exist in naïve sensory 
ganglia but they actively respond to neuronal stimulus. Naïve populations of resident tissue 
macrophages represent, phenotypically a hybrid of microglia and blood monocytes, expressing similar 
phenotypes distinct to both cell types. Thus, these cells may respond in similar but highly specialized 
manner to cellular changes in the dorsal root ganglia microenvironment.  
 The data presented here suggest that DRG macrophages have evolved to patrol and interact 
within the unique environment of the dorsal root ganglia. It is possible that the lack of blood brain 
barrier protection in DRG contributes to the phenotype of macrophages expressed in naïve and injured 
conditions. High expression of MHC Class II may provide ongoing antigen recognition ability 
required to protect neuronal cell bodies. Exposure of cells within DRG to pathogens and systemic 
cytokines is compounded by the highly vascular nature of the dorsal root ganglia, thus elevated 
patrolling and monitoring of pathogens may be warranted for neuronal protection. Furthermore, MHC 
Class II has been widely associated with pro inflammatory states of macrophages, suggesting that the 
primarily M2 characteristic macrophages we describe in naïve DRG may be primed for rapid 
conversion to M1 inflammatory macrophage activity under pathological conditions. The functional 
state of DRG macrophages may play a role in persistent pain development as evidenced by our data 
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showing rapid upregulation of MHC II and CD39 in the lumbar dorsal root ganglia following 
intraplantar injection.  
  Persistent pain may arise from aberrant continual inflammatory input, thus understanding the 
complex milieu of cytokine and chemokines in the dorsal root ganglia following peripheral injury may 
illuminate inflammatory mechanisms of persistent pain. Here we have shown distinct cytokine 
regulation in male and female mice following CFA injection in the hind paw. Interestingly, the 
cytokine milieu consists of both pro and trophic- inflammatory signals in both sexes indicating a 
complex immune response network. We hypothesize a biphasic response in which initial pro 
inflammatory cytokines are supplanted by trophic-inflammatory cytokines as normal inflammatory 
response dies down.  To confirm, these experiments will need to be repeated in neuropathic pain injury 
models. Our data indicate that in the time course of resolution, 3 days following CFA injection mice 
exhibit peak pain behaviors. Thus, the 3-day time point may be a turning point where both pro- and 
trophic inflammatory functions coincide. A complete time course will need to be completed to resolve 
overlapping immune response questions.  
 A consistent upregulation of serepin E1 was noted in both male and female CFA treated 
animals. We hypothesis that this finding may be indicative of a neuronal protective adaption by 
macrophages in which they reduce scar tissue formation following injury. Serepin E1 inhibits 
urokinase-type plasminogen activator (uPA) and tissue-type PA (1, 2) which both play a role in 
angiogenesis and extracellular matrix remodeling [88]. Thus macrophages may initiate a neuronal 
protective mechanism, by inhibiting scar tissue formation with the production and release of serpin 
E1 following peripheral injury. Further studies such as investigation of fibrin and extra cellular 
matrix remodeling following peripheral injury may further evaluate the role this may play in 
neuronal plasticity and pain processing.  
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 Communication between neuronal cell bodies and resident tissue macrophages may occur, 
especially under times of intense DRG neuronal stimulus, such as following distant injury or chronic 
pain states. To this end ectonucleotidase triphosphate diphosphohydrolase-1, CD39, hydrolyzes 
purinergic receptor ligands in specific P2 receptors ligands such as ATP. Neuronal expression of 
purinergic receptors able to respond to ATP and AMP the substrate and product of CD39 indicate a 
potential mechanism of communication between neurons and macrophages [62]. High naïve 
expression as well as upregulation following peripheral insult (CFA) indicate this potential 
communication mechanism is altered under pathological states and may provide an effect therapeutic 
target to further alleviate pain states.  
 Modulation of ATP to AMP by CD39, provides the substrate for subsequent enzymes such as 
CD73 which hydrolyze AMP to adenosine [62]. Adenosine has been implicated in numerous 
mechanisms of pain processing [86]. Receptors on sensory neurons such as A2AR have been shown to 
exhibit pro-nociceptive properties and may be activated by ligand production from resident tissue 
macrophages [87]. Thus regulation of purinergic ligands in the extracellular milieu by macrophages 
may impact pain processing and be a potential therapeutic target. Further pharmacological studies 
inhibiting CD39 will be needed to elucidate the therapeutic potential of anti-CD39 therapies. 
 Future studies involve macrophage response to purinergic receptor ligands, looking for 
calcium influx changes in the cell. Furthermore, identifying phosphorylation changes in macrophage 
following ATP exposure, will help elucidate the intracellular signaling cascade that may drive 
phenotypic as well as functional changes in resident tissue macrophages. Additionally, we hope to 
evaluate human DRG macrophages and acutely culture isolated macrophages form human tissue 
samples. Comparing human DRG macrophages to data collected in mice and rats will support or reveal 
limitations of these findings to human pain processing.  
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 Our findings suggest not only is there a significant population of resident tissue macrophages 
in the dorsal root ganglia but they are able to respond to distant insult with rapid phenotypic changes. 
Given the severe lack of treatment modalities for persistent pain, these discoveries may aid in the 
identification of therapeutic targets as well as our general knowledge of the pathological mechanisms 
of persistent pain.  
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CHAPTER 4 
 
 
PREAMBLE- The following chapter will be written in a narrative as it outlines the struggles as well 
as other preliminary data collected during my time in the lab.  
APPENDIX DATA 
 
METHODS 
von Frey- Tactile sensory thresholds were determined by applying von Frey filaments (North Coast 
Medical, CA) to the plantar surface of the left hind paw and recording the withdrawal response using 
the up-down method (Dixon, 1980). Mice were placed in a clear Plexiglas chamber with a wire mesh 
floor and allowed to habituate for 1 hour. Testing was conducted using filament sizes with respective 
bending gram forces of 0.04, 0.07, 0.16, 0.4, 1.0, 2.0 and 4.0, starting filament = 0.4 g. Filaments were 
pressed upward into the soft spot of the left hind paw until the filament was bent in half for a duration 
of 5 seconds. A response was recorded if the mouse expressed a lifting, shaking or licking behavior 
toward the hind paw during the application of the filament.  
Hargreaves - Thermal sensory thresholds were determined by assessing the latency of each mouse to 
respond to a noxious radiant heat source (Plantar Test, Ugo Basile, Italy; IR set to 28) (Hargreaves et 
al., 1988). Following a 60-minute habituation period, the heat source was positioned directly beneath 
the left hind paw to obtain withdrawal latencies. A maximal cut-off of 30 seconds was utilized to 
prevent tissue damage.   
Cell Fractionation – Cells were centrifuged at 150g for 5 minutes and supernatant removed. Cells 
were resuspended in 90 μl of HBSS (Ca2+/Mg2+ free) pH 7.2 with 10 μl of CD11b (Miltenyi Biotec) 
microbeads and placed on ice for 15 minutes. Added 2 mL of buffer (HBSS- Ca2+/Mg2+ free with 0.5% 
BSA) to cell suspension. Centrifuged cell suspension at 150Xg for 5 minutes. Aspirated supernatant 
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completely. Resuspended cell pellet in 500 uL of buffer (HBSS- Ca2+/Mg2+ free with 0.5% BSA). 
Fractionated cells through large cell column (MACS) in HBSS- Ca2+/Mg2+ free with 0.5% BSA. 
Unlabeled cells were further fractionated into neuronal and non-neuronal preparations.  
Percoll Gradient- Rapidly dissociated dorsal root ganglia were placed in 37% Percoll in 1x PBS and 
layered in a 15 mL conical tube with 2mLs of 70% Percoll, layered with 2 mLs of 37% Percoll with 
cells, followed by 2 mLs of 30% Percoll solution then 2mLs of HBSS. Centrifuge at RT for 30 minutes 
at 1760 rpm with no break on centrifuge. Harvest the 37/70 interface (mononuclear immune cells). 
Transfer into fresh culture media.  
 
 
 
 
 
 
 
 
Culture of human blood monocytes- Healthy monocyte differentiation assays: Peripheral Blood 
Mononuclear Cells (PBMCs) were isolated from whole blood by Ficoll-Paque gradient (GE 
Healthcare). Cells were cultured in a 5% CO2 incubator at 37 C in RPMI 1640 media supplemented 
with Gentamicin (8ug/ml) Penicillin /Streptomycin (100 UI/ml), human macrophage colony 
stimulating factor (M-CSF 20ng/ml), and 2.5% human plasma (from the PBMC donor) or 10% FBS. 
4 hrs. Post seeding all media was changed in all wells removing all floating cells. At 3 days following 
monocyte isolation 50% of the cell culture media will be replaced per day. On day 5, macrophage 
differentiation was initiated.  Cultures will be incubated for 2 days with no stimulation to create 
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undifferentiated controls; or either lipopolysaccharide (LPS 10ng/ml) and interferon gamma (50 
ng/ml) - to induce an M1 inflammatory macrophage differentiation - or transforming growth factor 
beta TGF-B (10 ng/ml) and interleukin 4 (IL-4 20 ng/ml) -for M2 trophic macrophage differentiation. 
Day 7, differentiated macrophages were detached from culture plates with 20 minutes of cold 
incubation and Versine buffer (0.02% EDTA) and gentle scraping.  
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RESULTS. 
 
 To investigate a means to remove neuronal cells from the dorsal root ganglia dissociation, we 
tried to use a Percoll gradient. Successful separation of mononuclear immune cells from myelin and 
most neuronal cells was achieved but due to the time and stress on the cells during the Percoll protocol 
many if not all macrophages exhibited autoflorescences (Figure 5.1). We subsequently tried to bead 
sort using Miltenyl Bead Sorting with pre conjugated magnetic beads against Cd11b (Cat#130-049-
601) however cell yield was low and only ~50% of cells survive the separation.  
 In addition to the above data we also collected information about the infiltration of neutrophils 
and macrophages into the dorsal root ganglia following peripheral injury. To this end, we found a 
decreased number of neutrophils and macrophages in the DRG following CFA administration (Figure 
4.2). Contrary elevated levels as expected were found in the blood of the animals following intraplantar 
injections of CFA. 
 Understanding the pathology of human dorsal root ganglia macrophages may be difficult as 
human samples require facilities and set ups that allow seamless transfer of the tissue in a timely 
fashion from the donor patient to the researcher. However, human isolated monocytes from leukopacs 
may give the first insight to possible interactions of resident tissue macrophages in the dorsal root 
ganglia of humans. Here we successfully isolated human monocytes from healthy donor blood and 
differentiated them into trophic and pro inflammatory types (Figure 5.3). 
 In an effort to explore novel therapeutics, CB2 agonist Gp1a was administered to mice 
following CFA injection. Behavioral testing indicated systemic (IP) injection of Gp1a during chronic 
pain states may attenuate pain more rapidly than saline treated counter parts (Figure 5.4).  
 The pain input of macrophages is still widely unknown; here we deplete resident tissue 
macrophages in ITGAM-DTR/EGFP female mice prior to CFA injection to understand the pain 
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behaviors of DRG resident tissue macrophage depleted mice. ITGAM-DTR-EGFP mice demonstrated 
a resistance to thermal pain as seen by a lack of hypersensitivity to IR behavioral tests (Figure 5.5). 
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Figure 4.1 
Flow Cytometry of naïve male CD115-Egfp, L2-L5 DRG following dissociation and Percoll gradient 
separation, all graphs gated on live singlet cells (a) Cd11b+ cells (b) Ly6G+ cells.    
  
 
59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2  
24 hours following intraplantar injection of either saline or CFA, female C57/B6N, L2-L5 DRG were 
rapidly dissected and dissociated and stained with various macrophage and neutrophil markers. 
CD115+CD11b+Ly6G- tissue resident macrophages unregulated CD39 (a) where grey histograms 
represent saline treated animals and teal CFA treated. Macrophage and Neutrophil percent of total 
CD115 cells reported in DRG. 
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                                                            Human blood monocytes  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 
Human macrophages were acutely cultured from human leukopacs. Top Row: Acutely cultured 
macrophages express CD11b and CD14 traditional macrophage lineage markers (A, B). 
Undifferentiated (grey), M1 (blue) or M2 (green) macrophages were induced. Control differentiation 
(C, D) expression changes in M1 marker HLA-DR and M2 marker CD206 are shown for reference. 
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Figure 4.4 
Von Frey and IR analysis of mice treated with GP 1a, a CB2 receptor agonist. Wild-type C57Bl6/J 
female mice were baselined prior to hind paw injection with Complete Freund’s Adjuvant (CFA) and 
intraperitoneal injection of 6mg/kg GP 1a or vehicle. Analyses were repeated at various points 
throughout the inflammatory state. 
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Figure 4.5 
CD11b+ cells were depleted in ITGAM-DTR/EGFP female mice via DTx injection. 24 hours post-
macrophage depletion, mice received hind paw injection with CFA and subjected to von Frey/IR 
analysis at several time points and compared to wild-type. 
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 Here our results show that Percoll separation does eliminate significant neuronal contamination 
as well as myelin from the DRG tissue preparation. However, the limited resident tissue macrophages 
isolated from the mouse lumbar ganglia limits the ability to successfully culture pure macrophage 
cultures, limiting the scope of our studies currently.  
 When evaluating the neutrophil and CD11b overall population in the dorsal root ganglia we 
saw a reduction of CD11b and Ly6G positive cells in the DRG whereas the blood saw a noticeable 
increase. This may be the result of activated immune cells tracking out of the dorsal root ganglia 
following injury, further supported by the high expression of the antigen presentation protein MHC 
Class II which may drive the cells to migrate to lymph nodes following injury to initiate an adaptive 
immune response. However further studies understanding the infiltration of blood monocytes and 
proliferation of resident tissue macrophages in response to injury is needed.  
 Human studies have also proven hard to conduct due to the limited access to fresh non fixed 
human dorsal root ganglia. Here we attempt to isolate blood monocytes from human leukopacs and 
differentiate them into pro or trophic states. Here we were able to establish an isolation and culture 
protocol of human blood monocytes as well as successfully differentiate these cells into a pro and 
trophic state as seen by marked upregulation of CD206 and HLA-DR (MHC Class II) on CD14+ 
human macrophages. Using human isolated macrophages, we can further begin to understand the 
potential response of DRG macrophages in human pain processing and their response to various 
purinergic agonist.  
 Presently, a small body of evidence suggests the existence of resident DRG macrophages and 
their phenotypic changes following insult. Supporting a link between macrophages and inflammatory 
pain, studies demonstrate that cannabinoid receptor type 2 (CB2) agonists attenuate pain in acute, 
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chronic, neuropathic, and inflammatory states and suppress pro-inflammatory cytokine release. 
Additional studies suggest macrophage activity is altered by CB2 activation.  
 Our findings suggest an analgesic effect following systemic GP 1a administration in a mouse 
model of inflammatory pain as well as diminished CFA-induced hypersensitivity in macrophage-
depleted mice. More studies should be conducted to confirm these findings and determine if DRG 
macrophages undergo phenotypic changes in response to insult or CB2 agonists. These data will be 
critical for determining the role of DRG macrophages in nociceptor remodeling and sensitization. The 
results of future studies may lead to the development of novel therapeutic approaches for the 
management of inflammatory pain. 
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MATERIALS USED.   
 
 
 
 
 
GENE Forward Primer Reverse Primer 
CD11b 5’-TTACGTAGCGAATGACCCCT-3’ 
 
5’-GTTTCACAAAACCAATGGGG-3’ 
 
CD39 5’-TCAGTCCCACAGCAATCAAA-3’ 5’-ACGAGGGAAGAGGAAGGAAA-3’ 
 
CD115 5’-AGGGCAACTGAGTAGGGTCA-3’ 
 
5’-CTCTGCTGGTGCTACTGCTG-3’ 
 
CD163 5’TGTATGCCCTTCCTGGAGTC-3’ 
 
5’-TGTGCAGTGTCCAAAAGGAG-3’ 
 
Arginase-1 5’TTTTCCAGCAGACCAGCTTT-3’ 
 
5’-GGAACCCAGAGAGAGCATGA-3’ 
 
CCL-2 5’- ATTGGGATCATCTTGCTGGT-3’ 5’- CCTGCTGTTCACAGTTGCC-3’ 
CSF-1 5’GGTAGTGGTGGATGTTCCCA-3’ 5’CCAGGATGAGGACAGACAGG-3’ 
